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Abstract
The pathological form of prion protein (PrPSc), as other amyloidogenic proteins, causes a marked increase of membrane
permeability. PrPSc extracted from infected Syrian hamster brains induces a considerable change in membrane ionic
conductance, although the contribution of this interaction to the molecular mechanism of neurodegeneration process is
still controversial. We previously showed that the human PrP fragment 90–231 (hPrP90–231) increases ionic conductance
across artificial lipid bilayer, in a calcium-dependent manner, producing an alteration similar to that observed for PrPSc. In
the present study we demonstrate that hPrP90–231, pre-incubated with 10 mM Ca
++ and then re-suspended in physiological
external solution increases not only membrane conductance but neurotoxicity as well. Furthermore we show the existence
of a direct link between these two effects as demonstrated by a highly statistically significant correlation in several
experimental conditions. A similar correlation between increased membrane conductance and cell degeneration has been
observed assaying hPrP90–231 bearing pathogenic mutations (D202N and E200K). We also report that Ca
++ binding to
hPrP90–231 induces a conformational change based on an alteration of secondary structure characterized by loss of alpha-
helix content causing hydrophobic amino acid exposure and proteinase K resistance. These features, either acquired after
controlled thermal denaturation or induced by D202N and E200K mutations were previously identified as responsible for
hPrP90–231 cytotoxicity. Finally, by in silico structural analysis, we propose that Ca
++ binding to hPrP90–231 modifies amino
acid orientation, in the same way induced by E200K mutation, thus suggesting a pathway for the structural alterations
responsible of PrP neurotoxicity.
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Introduction
Prion diseases, also called transmissible spongiform encepha-
lopathy (TSE), are fatal neurodegenerative disorders of humans
and animals characterized by sporadic, inherited and infective
(transmissible) aetiology, including, among the human diseases,
Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler-Scheinker
disease, fatal familial insomnia and kuru [1,2]. The epidemic
nature of TSE in domestic and wild animals constitutes a serious
health problem also for humans. In fact, in past years the
appearance of a new variant of CJD, associated to the
consumption of bovine spongiform encephalopathy-contaminated
beef, created a troubling new scenario in the transmission of prion
diseases [3]. TSE are invariably fatal, with death occurring
frequently in less than 1 year after the first symptoms appear [4].
From a neuropathology point of view TSE are characterized by
cerebral spongiform degeneration, loss of neurons and gliosis,
often associated with amyloid deposition [1]. According to the
‘‘protein only’’ hypothesis [5], TSE share a common pathogenic
event: the posttranslational misfolding of a membrane-anchored
glycoprotein (cellular prion protein, PrPC) into a protease-resistant,
aggregation-prone isoform (PrPSc). PrPSc is considered the main, if
not the solely, component of the prion, the infectious entity of TSE
[1]. PrPC-PrPSc conversion, physiologically prevented by energy
barrier, can occur as a spontaneous stochastic event, possibly
favored by mutations in the PrP gene (PRNP) or acquired by
infection with exogenous PrPSc molecules. The marked resistance
to proteolysis of PrPSc, generating fragments of 27–30 KDa (from
which the name of PrP27–30), determines its deposition, as
partially cleaved protein, in the extracellular space and the
formation of amyloid plaques. Neuronal rarefaction and gliosis
occur, although not invariantly, in brain areas where a significant
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PrPSc deposition is detectable, suggesting that the protein could
trigger the inflammatory and apoptotic cascades [6].
PrP fragments, corresponding to the protease-resistant portion
of PrPSc, are widely used to study PrP pathogenic refolding and
neurotoxicity. They are characterized by a flexible backbone that
can undergo to a conformational rearrangement proposed as a
model of PrPC-PrPSc conversion [7–10]. Although a definitive
general agreement has not been obtained yet, it was proposed that
these PrPSc-like fragments can transmit the disease after cerebral
inoculation in rodents [11–14], supporting the ‘‘protein only’’
hypothesis for the pathogenesis of TSE [5].
We developed a model to study the neurotoxicity of PrPSc using
a recombinant peptide encompassing residues 90–231 of human
PrP (hPrP90–231), This peptide, in its native form, is a soluble
monomer, mainly structured as a-helix, thus corresponding to a
model of PrPC [15]. hPrP90–231 can be converted by mild
thermal denaturation (1 hour at 53uC) in a b-sheet-rich
conformation that renders the peptide insoluble, highly hydro-
phobic and partially resistant to proteinase K [10,16]. All these
biochemical features that resembles a PrPSc-like structure, allow
hPrP90–231 to acquire biological activities in vitro, inducing
microglial activation, astrocyte proliferation and apoptotic neuro-
nal death [7,17–20]. Thus, also considering the recent demon-
stration that different prion conformations comprise the infectious
and neurotoxic entities [21], hPrP90–231 may represent a
valuable model to study prion neurotoxicity and the potential
development of novel therapeutic approaches [16,22].
Recently, we reported that Syrian hamster PrP27–30 was able
to induce a ionic current through a lipid bilayer and that this effect
was not mimicked by hPrP90–231 in its native a-helix-rich,
monomeric conformation [23]. However, when incubated in high
[Ca++] (10 mM), hPrP90–231 induced an effect super imposable
to that of PrP27–30 [23]. However, neither the current/voltage
relationship nor the relative increases of conductance in high
external calcium concentration suggests that the divalent ion
directly contributes to membrane permeability [23]. Thus, we
hypothesized that the binding of Ca++ to the peptide may induce a
conformational change in hPrP90–231 allowing a structural
conformation similar to the Syrian hamster prion. Numerous
studies have implicated alterations in Ca++ homeostasis in the
neuronal dysfunction in several neurodegenerative diseases,
including Alzheimer disease (AD) [24,25] and TSE [26,27].
Importantly, in AD, alterations of Ca++ signalling were bidirec-
tionally related to the activation of the amyloidogenic pathway
[24,28]. As far as TSE is concerned, most studies analyzed the
effects of PrPC and PrPSc as regulator (or deregulator) of neuronal
Ca++ homeostasis (for review see [27]), but a possible role of
altered [Ca++] in PrPSc-mediated neurotoxicity is still underscored.
Age-related deficits in neuronal [Ca++] regulatory systems are well
characterized, involving higher intracellular [Ca++], enhanced
Ca++ influx through voltage-sensitive calcium channels and
reduced capacity of mitochondria to buffer Ca++ excess [29].
Recently, it was proposed that Ca++ deregulation occurring during
the aging process may facilitate the formation of pathogenic Ab
peptides, which in turn further alter neuronal Ca++ homeostasis,
generating a vicious circle [30] that could occur also during TSE.
The principal aim of this study has been to highlight both the
structural features in PrPsc oligomers that push them in the toxic
amyloidogenic cascade and the relationship between the acquire-
ment of the toxic conformation with changes in the local
environment. For this purpose we used the recombinant
hPrP90–231 fragment, taking advantage on its conformational
dependent toxicity, as detailed above [7]. We evaluated the role of
high [Ca++], as determinant of the generation of PrP toxic
molecules, analyzing the structural features of hPrP90–231
conformer generated in these experimental conditions that are
able to induce the same biological effects of Syrian hamster
purified PrPSc. We demonstrate that Ca++ binding to hPrP90–231
induces a conformational change in the peptide resembling that
previously characterized as the neurotoxic conformer [7,10].
Importantly, in this PrPSc-like conformation, hPrP90–231 caused
cytotoxic and membrane destabilizing effects identical to those
induced by Syrian hamster PrP27–30, fully validating the
proposed model. Finally, we provide a molecular model of the
structural alterations induced by in the PrP molecule after Ca++
binding, in comparison with those induced by the disease-related
pathogenic mutation E200K.
Results
Effect of Calcium on Ionic Currents Elicited by PrP Forms
The Tip Dip technique allows single-channel recordings from
artificial lipid bilayer by drastically reducing the surface area
available for proteins to insert and, consequently, the background
electrical noise. Figure 1 highlight the different ionic permeability
induced in artificial membrane of PrP27–30 (left) compared to the
recombinant hPrP90–231 (right) in agreement with previous data
[23]. We also confirmed that hPrP90–231 conductance increases
in elevated calcium ion concentration (10 mM) without apparently
increasing the divalent ion flow through the membrane [23].
To separate the effect due to the transmembrane Ca++ ionic
flow from any other possible interaction of divalent ions and PrP
peptide or the influence of high [Ca++] on the lipid bilayer, we
here recorded single channel events induced by the recombinant
peptide in Tip Dip experiments using two procedures. In the first
one, a classical dose/response curve was obtained changing [Ca++]
in the recording pipette. The second procedure consisted in one
hour pre-incubation of the PrP peptide in the different Ca++
solutions. After this period hPrP90–231 was resuspended (dilution
1:500) in the control trans solution (1.8 mM CaCl2) just before
performing the electrophysiology measurements. The results in
Figure 2 show that the effect of the different [Ca++] on membrane
conductance is similar either using the divalent ion directly in
contact with the bilayer or after one hour incubation. The
current/voltage relationships (i/Vs) on the top of Figure 2 depict
in both cases two distinct groups of data: current values obtained
with the peptide exposed to 1.8 and 5 mM Ca++ and a second set
of data concerning 10, 20 and 50 mM [Ca++]. The histograms in
the bottom of Figure 2 highlight the difference between calcium
concentration growth (vertical bars) and the increase of single
channel conductance (chart boxes). At high [Ca++] (10, 20 and
50 mM) conductance values remain constant for both the
experimental procedures. Clearly, this cannot be ascribed to a
saturation of Ca++ permeability since current data obtained using
pre-incubated hPrP90–231 (white bars) were recorded in physi-
ological [Ca++].
Effect of Calcium on in Vitro Cell Toxicity of PrP Forms
Data showed in Figure 2 suggest that membrane conductance
increasing following the Ca++ treatment is mediated by changes in
hPrP90–231 structural features rather than in the lipid bilayer
permeability properties. We previously characterized the confor-
mational changes of hPrP29–231 causing gain of toxicity: hPrP90–
231 can acquire toxic properties by mild thermal denaturation
(53uC, 1 hour) [7,22], allowing hPrP90–231 to be highly
internalized into SH-SY5Y in insoluble aggregates that caused
lysosomal dysfunction and cell apoptosis [18]. In Figure 3 panel A
the toxic properties acquired by hPrP90–231 after the thermal
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denaturation were compared with those elicited following the
incubation with increasing calcium concentrations. The results
showed that the pre-incubation of hPrP90–231 with 1.8 mM Ca++
was peculiarly devoid of any effect on SH-SY5Y cell viability while
5 mM Ca++ resulted in moderate cell death. Indeed, preincuba-
tion with 10 mM Ca++ did induce a cell toxicity comparable to the
thermal denatured peptide, after 2 days of treatment. These data
are all the more meaningful if we consider that the culture medium
itself contains high [Ca++]. Interestingly, the level of in vitro
cytotoxicity induced by thermally denatured and calcium treated
hPrP90–231 is similar with that elicited by brain extracted Syrian
hamster PrP27–30 (Fig. 3A).
In the histograms of Figure 3B we compare the membrane
conductance obtained using the manipulated hPrP90–231 peptide
in Tip Dip experiments, using the same treatment reported in the
cytotoxicity experiments depicted in Figure 3A. After mild thermal
denaturation as well as after pre-incubation in high [Ca++]
hPrP90–231 drastically increases membrane conductance to a
level similar to that induced by PrP27–30. These results suggest
that mild thermal partial denaturation and high [Ca++] play a
similar role on the functional activity of the peptide that seems to
be not linked to an increase of calcium ion permeability. We
hypothesized that Ca++ binding to the peptide is responsible of a
rearrangement of its conformation to acquire similar characteris-
tics to those obtained during the thermal denaturation procedure.
To probe this hypothesis, we pre-incubated hPrP90–231 in a
solution containing 10 mM CaCl2. Just before testing the peptide
in the Tip Dip apparatus, we diluted (1:500) the solution to reach
1.8 mM [Ca++] (Fig. 3B). Also in these experimental conditions
hPrP90–231 greatly affected ionic conductance. Even if thermal
denaturation procedure showed a bigger impact on membrane
conductance, pre-incubation with 10 mM Ca++ caused a substan-
tial increase of ion membrane permeability and the two values that
were not statistically different (n = 14). Similarly, applying the
same protocol, we demonstrate that hPrP90–231 preincubated
with 10 mM Ca++and then diluted to 1.8 mM, retains also its toxic
effects (Fig. 3A). Finally the effects of incubation with 10 mM Ca++
and thermal denaturation were not additive, as far as both cell
toxicity and membrane conductance (Fig. 3A and 3B), supporting
the hypothesis that the two protocols may induce the same
structural alterations. The effects of 10 calcium was prevented by
addition of EGTA into the incubation medium. 25 mM of the
divalent ion chelator mixed with 10 mM calcium results in a final
calcium concentration of 1.6 mM (Clampex, Molecular Device,
Novato CA) (Fig. 3A and B). As a control, both in toxicity and lipid
bilayer conductance experiments, we use a purified GST protein
at the same concentration of hPrP901–231. In three different
experimental conditions, 1.8 and 10 mM Ca++ as well as after
thermal denaturation at 53uC, there was no significant cell toxicity
(2% 65, 4% 63 and 0% 69, respectively) neither evident
transmembrane ionic flow activity. In Figure 3A and B we report
only the results of GST preincubated with 10 mM Ca++.
The general idea coming out from our experiments is that a
direct link exists between membrane ionic conductance, promoted
by the PrP after different treatments, and the ability of the same
peptide to be harmful for the cells: larger conductance results in a
higher level of toxicity.
Relationship between cytotoxicity and perturbation on the
membrane ion conductivity was also tested for single point
mutated forms hPrP90–231(E200K), that has been demonstrated
[17] to be much more toxic in its native conformation than the wt
recombinant peptide or the hPrP90–231(D202N) form, bearing a
different point mutation (Fig. 3C and D). Partial denaturation
procedure or the exposure to high calcium level did not change the
E200K mutant powerful effects on cell viability while it causes
Figure 1. Comparison between PrP27–30 protein and hPrP90–231 peptide in Tip Dip electrophysiological experiments. Fifteen
consecutive current recordings obtained at 80 mV membrane potential are shown for infected- brain-extracted protein (panel A) and recombinant
PrP peptide (panel B). Panels C and D depict corresponding current amplitude histograms. Histograms were built at each test potential and used to
calculate the ionic pathway conductance in the current/voltages relationship showed in the bottom of the figure (panels E and F). From the linear
regression of the experimental points (dotted lines) we calculate a conductance of 7260.23 to 2460.7 pS for PrP27–30 protein and hPrP90–231
peptide respectively (n = 5).
doi:10.1371/journal.pone.0038314.g001
Figure 2. Calcium concentration modulates the ionic conduc-
tance induced by hPrP90–231 recombinant peptide. A: current/
voltage relationship obtained from Tip Dip experiment using the
peptide in 5 different calcium concentrations. B: the current/voltage
relationships were obtained from experiments performed in 1.8 mM
calcium concentration but the peptide was prior incubated for 1 hour in
4 different calcium concentrations. C: the histogram shows the
conductance values versus calcium concentrations either present in
the external solution during the experiment or only used during
hPrP90–231 incubation. The conductance in the two different
conditions show similar values and reaches its maximum at 10 mM
calcium. Black and white bars visualize the calcium increase (n = 5).
doi:10.1371/journal.pone.0038314.g002
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drastic change in D202N. Conductance values calculated here by
Tip Dip technique are 2462.1 and 8062.2 pS for D202N and
E200K mutants, respectively. Thereby, the membrane conduc-
tance change induced by the two mutations proved that while the
hPrP90–231(D202N) shows a same conductance value of the w.t.
peptide, hPrP90–231(E200K) induces a high level of ion
conductivity already in its native conformation paralleling its
effects on SHSY5Y cell survival. The exposure to high calcium
level did not change the E200K mutant powerful effects on
membrane conductance; on the contrary, mimicking the native
recombinant, the peptide bearing the D202N mutation increases
cytotoxicity and conductance in the presence of both partial
denaturation procedure or high calcium exposure (Fig. 3C and D).
Relationships between PrP27–30- and hPrP90–231 Forms
Induced Ionic Current and Cell Toxicity
From all these experiments cell toxicity and membrane
conductance appear to be strictly correlated. To demonstrate this
relationship we performed a linear regression analysis comparing
the amount of cell death and the ionic conductance of hPrP90–
231 w.t. and the mutants using the data obtained in all the
previous experiments. The plot depicted in Figure 4 shows 18
different data points obtained in parallel electrophysiological and
cell survival experiments in several different conditions, including
the non pathogenic GST protein. There is a good correlation
between the toxicity data and the increase of membrane
conductivity operated by the diverse PrP peptides tested in all
the different conditions, showing a highly statistical significance
(regression coefficient, R2: 0.93, P,0.0001, Fig. 4).
Finally, to demonstrate the relationship between ionic conduc-
tance and cell toxicity in experimental conditions in which the
structural alterations of hPrP90–231 may spontaneously occur, we
evaluated the effects of the peptide after its prolonged incubation
at 37uC before being added to the cells (toxicity experiments) or to
the lipid bilayer (electrophysiology experiments). In fact, we
previously suggested that thermal denaturation at 53uC catalyzes a
spontaneous process already occurring at 37uC, reducing the time
required for the structural alterations responsible of the gain of
toxicity of hPrP90–231 [7]. In line with this hypothesis, we
demonstrated that prolonged incubation at 37uC (5 to 24 hrs)
favored the acquisition a conformation highly toxic for SH-SY5Y
cells in culture (Fig. 5A). Importantly, the same treatment also
increased ionic conductance (Fig. 5B), further correlating the two
phenomena. For comparison to the two plots were added grey
horizontal bands representing the range of high toxicity associated
with a large conductance obtained treating hPrP90–231 for a very
short time in different conditions (see Fig. 3). Longer pre-
incubations at 37uC (5, 15, 24, and 48 hrs) showed a lower
response in terms of cell death and higher ionic conductance
(Fig. 5A, B). At 72 hours the almost total recovery of cell viability is
not followed by a decrease in ionic membrane conductance. This
is probably due to the few highly reactive oligomers left during the
Figure 3. Toxicity versus membrane ionic conductance of the hPrP90–231 peptide. Histograms in panel A and B compare neuroblastoma
SH-SY5Y cell death percentage and Tip Dip membrane ionic conductance of PrP27–30 protein (scrapie) with hPrP90–231 peptide in different
experimental condition reported below each histogram. In panel C and D the same parallel study was done using two different hPrP90–231 mutants:
D202N and E200K. Cell death was measured using the MTT assay after 48 hours of treatment. * = p,0.01 vs. scrapie-induced effects.
doi:10.1371/journal.pone.0038314.g003
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aggregation process. These results are in line with our previous
reports showing that long thermal denaturation treatments favors
hPrP90–231 aggregation on preamyloid fibrils [48] that cannot be
internalized by the cells and are not cytotoxic [48,49]. Thus, we
can hypothesize that these macroaggregates/prefibrillar structures
may less efficiently interact also with the artificial lipid bilayer to
induce a reduced ionic conductance.
Effects of Ca++ Binding of hPrP90–231 Structure
To directly monitor the effects of Ca++ on hPrP90–231
structure, we analyzed several parameters that previously we
demonstrated to be determinant for the gain of toxicity of
hPrP90231. By CD analysis, we demonstrated that hPrP90–231,
which in its native conformation is mainly a-helix structured
(Fig. 6A), in the presence of increasing [Ca++], loses its
structuration. A similar structural change occurred after thermal
denaturation at 53uC [7]. Higher [Ca++] caused a reduction of the
spectroscopic signal likely due to the aggregation of the peptide. By
means of ThT binding assay, as index of b-sheet content, we also
show that incubation of hPrP90–231 with 10 mM Ca++ induced
an increase in the fluorescence emission (C-max) slightly higher
than that induced by thermal denaturation (Fig. 7), suggesting the
likely occurrence of increasing in the b-sheet content as a
consequence of incubation in high [Ca++] as demonstrated after
thermal denaturation. In fact, no additivity on ThT binding was
observed combining the two treatments on hPrP90–231 (Fig. 7).
hPrP90–231 N-terminus structural unfolding in the presence of
high [Ca++] was also monitored by measuring the intrinsic
fluorescence of the unique tryptophanylic residue located in the
position 99 of the hPrP90–231 sequence. Incubation of the peptide
with 1.8, 5 and 10 mM Ca++ caused a concentration-dependent
increase in fluorescence emission that was comparable to that
induced by thermal denaturation (data not shown). Similar results
were also obtained evaluating the hydrophobicity of the peptide: as
observed after thermal denaturation [7], increasing [Ca++]
induced a higher hydrophobic amino acid exposure on hPrP90–
231 surface as measured by TNS binding (Fig. 8A).
Finally, one of the hallmarks of pathogenic PrP is proteinase K
resistance, which can be induced in hPrP90–231 by thermal
denaturation [7]. Incubation with Ca++ (5 and 10 mM) signifi-
cantly increased the resistance of hPrP90–231 to proteinase K
digestion, with the effect induced by the concentration of 10 mM
comparable to that caused by incubation at 53uC for 1 hr (Fig. 9).
Conversely, hPrP90–231 in native conformation, or after the
incubation with low [Ca++] (1.8 mM), was completely digested
even at the lowest PrP/PK ratio (500/1) (Fig. 9).
Similar results were obtained using hPrP90–231 mutants. E200K
mutation that per se shows high TNS binding (Fig. 8B) and tryptophan
Figure 4. Correlation between toxicity and membrane conduc-
tance of hPrP90–231 peptide. All the experimental conditions data
reported can be compared with the PrP27–30 protein data (1)
representing the native pathological prion protein. Data are plotted
as linear regression and statistical evaluation was performed by ANOVA.
doi:10.1371/journal.pone.0038314.g004
Figure 5. hPrP90–231 peptide incubation time course in
physiological condition of cell viability (A) and membrane
ionic conductance (B). hPrP90–231 was incubated at 37uC in 1.8 mM
Ca++, for different times, before being used in cell viability (MTT assay)
or Tip Dip experiments. The grey horizontal bar in both plots represents
the range of high toxicity (Fig. 5A) and the corresponding range of high
conductance (Fig. 5B) obtain treating hPrP90–231 in different
conditions (see Fig. 3). The two plots show that between 15 and 24
hours of hPrP90–231 incubation there is a minimum cell viability and a
maximum membrane conductance values.
doi:10.1371/journal.pone.0038314.g005
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fluorescence (data not shown) showed a moderate further increase in
these values, reaching the same values observed in the w.t. peptide
(Fig.8A).Wepreviously reportedasimilarbehavioralsoafter thermal
denaturation[17].As faras secondarystructure,hPrP90–231E200K
that is natively rich inb-sheet [17], after incubation in high [Ca++] no
significant changes were observed as farasb-sheet content although a
loss of signal was observed, likely due to protein aggregation (Fig. 6B).
Againasimilarproteinbehaviorwasdetected inprevious studiesafter
thermal denaturation [17].
D202N mutation that mildly affected native hPrP90–231
structure [17], acquired increased hydrophobicity (Fig. 8C) and
N-terminal tryptophan exposure (data not shown) after incuba-
tion in high [Ca++], resembling the structural alterations
Figure 6. Effect of Ca++ on secondary structure of hPrP90–
231 w.t. (A) and bearing E200K (B) or D202N (C) TSE-related mutations.
A. CD analysis of hPrP90–231w.t. in the presence of increasing
concentrations of Ca++ (mM: 0 = ___; 1.8 = ; 5 = ; 10 = ). A. A loss of a-
helix structure and increase in b-sheet content was observed in the w.t.
peptide for increasing Ca++ concentrations that was associated, at the
highest concentrations to a loss of spectrophotometric signal, likely due
to protein aggregation. B. CD analysis of hPrP90–231 E200K mutant in
the presence of increasing concentrations of Ca++. The peptide
structure, already enriched in b-sheet content, is not significantly
affected by the incubation with the ion. C. CD analysis of hPrP90–231
D202N mutant in the presence of increasing concentrations of Ca++.
Incubation in high Ca++ concentration reduce the a-helix content,
although showing a lower sensibility than the w.t. protein. At the
highest concentration tested a loss of spectrophotometric signal
occurs, likely due to protein aggregation.
doi:10.1371/journal.pone.0038314.g006
Figure 7. Thioflavin T binding to hPrP90–231 w.t. HPrP90–231
in native, conformation, after mild thermal denaturation (536C,
for 1 hr), after incubation for 1 hr in the presence of 10 mM
Ca++, or after a combination of both treatments was tested for
Th T binding in a fluorimetric assay, as index of b-sheet
content. As previously reported, thermal denaturation increased the
Th T binding as compared to the native peptide, but this effect was
slightly higher after incubation with Ca++. No additivity between
thermal denaturation and incubation in the presence of 10 mM Ca++
was observed.
doi:10.1371/journal.pone.0038314.g007
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observed after thermal denaturation [17]. Interestingly, CD
analysis showed that a-helix content remained unchanged in the
presence of Ca++ (Fig. 6C), as was previously described after
thermal denaturation [17]. Thus, to conclude this part of the
study we propose that the biological effects induced by hPrP90–
231 incubation in high [Ca++] are due to a structural
rearrangement that induce a conformational change closely
related to the toxic conformation we previously described after
mild thermal denaturation [7,17,48].
Molecular Modeling
Here, the structural and electrostatic changes occurring as a
result of the E200K mutation and the binding of the Ca2+ ion on
the PrP90–231 structure were analysed, in comparison to the w.t.
protein, by means of molecular mechanics based approaches and
electrostatic potential similarity analyses. The computational
protocol we used is based on the combination of LLMOD
searches and multiple minimizations and allowed to develop
reliable models for (i) the wild type PrP90–231 protein (model I)
and its E200K mutant (model II), whose NMR structures are
already well known [38,39], and (ii) the binding of the Ca++ ion by
the Pr90–231 segment of PrPC (model III) that is still unknown
and is the main goal of this study. The similarity between the
electrostatic potential at the proteins surface was then evaluated
for these models employing the Carbo´ similarity index (see
Material and methods). This procedure allowed us to propose a
molecular model for the binding of the Ca++ ion to PrPC protein
and suggest possible structural and electrostatic alterations
responsible for the increased neurotoxicity.
Structural, Charge and Similarity Analyses of w.t. PrPC
and the E200K Mutant
Preliminarily, we evaluated the predictive performance of
models I and II in reproducing the experimental behaviour of
the w.t. hPrP90–231 protein and its E200K variant. Both proteins
include a globular domain, residues 125–228, containing three a-
helices comprising the residues 144–154 (H1), 173–194 (H2), and
200–228 (H3) and a short anti-parallel b-sheet comprising the
residues 128–131 and 161–164 (Fig. 10, left panel). A comparison
of the NMR structures of these two proteins shows, in spite of the
Glu200RLys substitution, an almost identical overall structure,
even in the vicinity of residue 200. Indeed, except for the loss of
the Glu200-Lys204 salt-bridge interaction within the H3 helix and
significant alterations in the highly flexible loop 167–171, only
minor differences in interdomain interactions are observed.
Particularly interesting is the H-bond pattern, involving the
Arg156, His187 and Thr191 residues and connecting the C
terminus of H1 and H2 in the w.t. protein (Fig. 10, left panel), that
is lacking in the E200K variant Fig. 10, right panel). These
structural differences are all nicely reproduced by our models I
and II thus validating our MM approach.
In spite of the almost identical three-dimensional structure, the
Glu200R Lys substitution has important effects on the charge
distribution at the protein surface. Indeed, the replacement of the
Figure 8. Effect of Ca++ on hydrophobic amino acid exposure,
measured by TNS binding, of hPrP90–231 w.t. (A) and bearing
E200K (B) or D202N (C) TSE-related mutations in the presence of
increasing concentrations of Ca++ (mM: 0 = __; 1.8 = ; 5 = ; 10 = ). As
internal control, the direct effect of 10 mM Ca++ on TNS is reported (+).
A. TNS binding assay of hPrP90–231 w.t after incubation with
increasing concentrations of Ca++ show a great increase in TNS binding,
indicating the increased hydrophobicity of the peptide. B. TNS binding
assay of hPrP90–231 E200K showed a basal higher hydrophobicity than
the w.t. peptide, although in the presence of increasing concentrations
of Ca++ TNS binding greatly increased, indicating increased hydropho-
bicity of the peptide C. TNS binding assay of hPrP90–231 D202N in the
presence of increasing concentrations of Ca++. In these experimental
conditions the hydrophobicity of the peptide greatly increased, as
indicated by the TNS binding fluorescence although reaching lower
levels than observed with the other peptides.
doi:10.1371/journal.pone.0038314.g008
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negatively charged Glu with a positively charged Lys residue
results in a dramatic redistribution of the surface charges
introducing patches of positive potential around the beginning of
helix 3, and has been suggested to facilitate the PrPC to PrPSc
conversion by promoting protein-protein interactions and aggre-
gation [39].
The effects of the mutation on the electrostatic properties of
PrPC was then investigated in detail by analyzing the similarity
between the molecular electrostatic potential (MEP) near the
surface of the wild type (model I) and the E200K mutant (model II).
Such an analysis was the performed by calculating the Carbo´
similarity index (sC) [47] (see Materials and Methods) between the
two MEPs on the points of a grid encompassing the superimposed
protein models (I U II). Moreover, because the H3 helix has been
suggested to play a key role in the disease-related conformational
transformation of PrPC to PrPsc in vivo [50], and is also directly
involved in the considered E200K mutation and (see below) in the
binding of Ca2+ ions, we have perform our similarity analysis with
respect to its axis (approximately corresponding to the x-axis in the
workspace coordinates of Maestro, see Computational Details).
Accordingly, the grid space was partitioned into slices perpendic-
ular to the x axis, and the similarity index was calculated on each
Figure 9. Increased proteinase K (PK) resistance of hPrP90–231 w.t. in the presence of increasing Ca++ concentrations. hPrP90–
231 w.t. was thermally denatured or preincubated with increasing concentration of Ca++ before being subjected to PK digestion with different
enzyme concentrations. Partial resistance was evaluated in Western blot experiments using the anti-PrP antibody 3F4. Left panel shows
representative immunoblots, while the graph on the right depicts the densitometry analysis of three independent experiments. Data are expressed as
percentage of the respective recombinant peptide input. * = p,0.05 and ** = p,0.01 vs. control values. In native conditions or in the presence of low
Ca++ concentrations, the peptide showed no resistance to PK digestion. After incubation with 5 or 10 mM Ca++ a partial resistance was observed for a
peptide/PK ratio of 500:1. Thermal denaturation induced a higher resistance as compared to Ca++ binding, being the immunolabeled peptide band
detectable also for a peptide/PK ratio of 200:1.
doi:10.1371/journal.pone.0038314.g009
Figure 10. Structure of the proposed Ca++ binding site in the wild type PrP90–231 protein. On the left the site with the residues still
involved in an H-bond pattern in model I (light cyan); on the right the resulting complex after Arg156 shift and Ca++ binding in model III (orange).
Hydrogen bonds (dotted red) and coordinative bonds (green) are explicitly indicated.
doi:10.1371/journal.pone.0038314.g010
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slice and the MEP similarity was monitored as a function of their
position along the x axis.
The plot of the I/II similarity index, reported in Figure 7, shows
two minima at 22–23 A˚ and at 62–63 A˚ along x axis, at the
beginning and close to the C terminus of H3, respectively (see
Figure 11 and S2).
The first minima is due to the completely different orientation of
the charged Glu168 and the Tyr169 residues in the highly flexible
loop 167–171 which significantly differs in the two protein forms.
More importantly, the lowest minimum at 62–63 A˚, characterized
by a negative value of –0.25 of the Carbo´ index (indicating a large
MEP similarity) encompass the region around the protein surface
around H1, the C terminus of H2 and the beginning of H3, and
comprising the residue at position 200 (Fig. S2). This region also
includes the Arg156, His187 and Thr191 residues involved in the
H-bond pattern connecting the C terminus of H1 and H2 in the
w.t. protein (model I) and switched off in the E200K mutant
(model II). The presence of a deep I/II similarity minimum in this
region indicates that significant changes in the charge distribution
has occurred therein as a consequence of E200K mutation, and is
not surprising because of the charge inversion associated to the
E200K mutation and the breaking of the H-bond pattern
connecting H1 and H2. The graphical inspection of the protein
in this region revealed a significant shift of Arg156 as a
consequence of E200K mutation: indeed, while in model I the
side chain of this residues is directed toward the protein interior, in
model II it protrudes outside the protein surface and this shift
could contribute to the negative values of I/II similarity index
around 62–63 A˚.
Binding of Ca++ to the Wild Type PrPC
The building of a molecular model for the binding of the Ca2+
ions to the PrPC wild type protein (model III) was carried out on
the basis of an inspection of the MEP and of the distribution of
potentially coordinating side chains around the w.t. protein
surface, suggesting a plausible metal binding site in the close
proximity of His187, Thr191 and Glu196. Although His187 and
Thr191 are involved in an H bond pattern with Arg156, that also
contributes to keep them in close proximity (Fig. 10, left), this
pattern can be easily broken, as shown by the analysis of the
E200K mutation above. We thus hypothesized that Arg156
guanidine could shift from its position in the w.t. PrPC allowing the
Ca2+ ion to coordinate the His187 and Thr191 and the nearby
Glu196. The structure of the resulting PrPC-Ca2+ complex (model
III) was calculated by using the same computational approach
employed for the calculation of models I and II. The Ca2+
coordination site resulting by our computational approach
involved His187, Thr191, Glu196 (g2 coordination) and the
backbone carbonyl oxygen of Arg 156 arranged in an distorted
square-planar coordination (Fig. 10, right).
The effects of Ca2+ coordination on the electrostatic properties
of PrPC were evaluated by the analysis of the MEP similarity of
model III with models I and II using the same approach described
above. The most important feature of the analysis of the I/III
MEP similarity as a function of their position along the x axis is the
presence of a negative minimum at 62–63 A˚, with the same
position and similarity values of the minimum observed for the I/
II similarity (Fig. 11). This result clearly indicates that, the effect of
Ca2+ coordination is very similar to that induced by the E200K
mutation, leading to a redistribution of the surface charges with
patches of positive potential around the beginning of H3.
This conclusion was further supports by the analysis of the of II/
III MEP similarity which showed relatively high similarity values
(higher than 0.50) at 60–65 A˚ along the x axis, indicating similar
electrostatic properties of models II and model III at the beginning
of H3.
Discussion
PrP misfolding is the pathogenic event responsible of the clinical
and pathological features of TSE, including neurotoxicity and
transmissibility [51]. To date, the exact mechanisms by which the
transition PrPCRPrPSc may occur, as well as the final conforma-
tion providing PrPSc with gain of toxicity have not been
Figure 11. Plot of the Carbo´ similarity index (sC) for the MEPs of models I-III as a function of the position along the x axis.
doi:10.1371/journal.pone.0038314.g011
Calcium Dependent Prion Protein Toxic Conformation
PLoS ONE | www.plosone.org 10 July 2012 | Volume 7 | Issue 7 | e38314
completely elucidated. However, in the past years, several studies
using recombinant PrP molecules highlighted potential mecha-
nisms by which misfolded PrP may cause cell death and potential
molecular determinants of such effects [51]. We developed an
experimental model to study PrP neurotoxicity using an amino-
terminally truncated PrP isoform (PrP90–231) that can transit
from a PrPC-like to a PrPSc-like conformation by mild thermal
denaturation. In these conditions hPrP90–231 become b-sheet
structured, highly hydrophobic, amyloidogenic and neurotoxic. In
this study we analyzed different and possibly more physiological
mechanisms of hPrP90–231 transition toward the neurotoxic
conformation, evaluating the role of Ca++ in this process.
Moreover, comparing the effects of the recombinant protein with
PrP27–30 isolated from infected hamster brain, we identified an
altered ion current in synthetic lipid bilayers as marker of the
interaction of neurotoxic PrP molecules with cell membranes.
It is a whispered characteristic of amyloid compounds to be able
to interact with lipid bilayers [52–54]. Not only amyloid
compounds are found in close association with cell membrane
but also they are responsible to cause a vast variety of
electrophysiological transmembrane signals [55]. PrP is not an
exception. Several investigations report the ability of PrP to induce
changes in ionic conductance both in artificial [56,57] and cell
[58] membranes. Whether PrP is able to form structures similar to
conventional ion channels is still debatable. Whether the induction
of ion flux is part of the toxicity mechanism responsible for cells
death during insurgency of the pathological condition it is even
more controversial [59].
In a previous report we demonstrate that PrPSc purified from
infected hamster brain is able to open ionic conductance in which
the most probable current level is around 80 pS. On the contrary
the recombinant peptide, hPrP90–231, composed by the same
amino acid primary sequence shows an average conductance of
20 pS [23]. In the present investigation we confirm these data and
correlate the ionic conductance value with the toxicity level
obtained in neuroblastoma cell culture. Cell death percentages
follow proportionally the measured conductance calculated for the
different conditions in which we treated the PrP90–231. Patho-
logical PrPSc appears to be 5 folds more harmful when compared
with recombinant peptide in its native, a-helix structured
conformation. The arrangement of the secondary structure of
PrP peptides is known to determine their cytotoxicity. Recombi-
nant hPrP90–231 peptide is a versatile model to study the
conformation-dependent toxicity [7,10]. In a previous study it was
demonstrated that both mild thermal denaturation and the
conformational changes induced by TSE-related point mutations
drastically increases cell toxicity [17]. Here, using hPrP90–231 in
Tip Dip experiments, we demonstrate that a higher level of cell
death correspond to a higher membrane conductance values
reaching values comparable to those induced by PrP 27–30.
Importantly, similar results were obtained incubating w.t. and
mutant hPrP90–231 molecules with increasing Ca++ concentra-
tions. In these experimental conditions PrP truncated peptides
increased ionic conductance and toxicity, with a highly significant
direct relationship. Since these experimental conditions determine
a rearrangement of the tridimensional structure of the peptides, we
can conclude that the key conformational features present in the
hamster prion responsible of the membrane interaction are likely
reproduced in hPrP90–231.
This is the first evidence that biological and electrophysiological
characteristics of brain extracted PrP27–30 can be entirely
reproduced by recombinant PrP fragments. Moreover, these
results further support the use of hPrP90–231 for identification of
the mechanisms of neuronal dysfunction and neurotoxicity in TSE
patients and for the identification of potential new pharmacolog-
ical approaches to be translate in clinical setting [22,49].
The second relevant observation coming out from this study is
that the same neurotoxic conformation we previously described to
be induced by mild thermal denaturation can be reproduced in the
presence of high [Ca++]. In particular, accordingly to our
molecular modeling, to induce hPrP90–231 gain of toxicity,
Ca++ binding to the recombinant peptide might induce hPrP90–
231 aggregation that, in turn, is responsible of alterations in the
peptide three-dimensional structure, increasing of its hydropho-
bicity, and, finally inducing a partial resistance to protease K
digestion. These observations suggest two additional consider-
ations: 1) hPrP90–231, likely due to the N-terminal truncation,
show reduced energy barrier and thus is more prone to adopt a
neurotoxic conformation in different environmental conditions
(mild thermal denaturation, high divalent ion concentrations); 2)
the highly reproducible induction of the same biological effects by
hPrP90–231, independently of the means used to induce the
conformation change, suggest that this transition may represent
the (or one of the) neurotoxic PrP conformation(s) in vivo.
In this scenario the role of Ca++ on PrP peptide function it is of
fundamental importance. Increase of [Ca++] from physiological
levels up to 10 mM is directly responsible of the conformation
changes that allow acquisition of the two main biological features
identified in hPrP90–231: activation ionic conductance and
increased toxicity. To understand how Ca++ binding can induce
such a dramatic structural alteration, we performed in silico
structural analysis comparing the amino acid charge distribution
of PrP w.t. in the absence or presence of Ca++ binding in a specific
coordination site, with the model of PrP E200K. In fact, from
previous studies we identified two TSE-related PrP mutations
(D202N, E200K) that differently affected PrP a-helix 3 stability
[35]. Importantly, E200K mutation induces in hPrP90–231 a
spontaneous acquisition of the toxic and ionotropic conformation,
independently from thermal denaturation [17] or Ca++ binding.
Thus, we verified were the three-dimensional alteration induced
by the E200K mutation could be mimicked by Ca++ binding to
PrP90–231. Our in silico study confirmed this hypothesis showing
that Ca++ binding can occur in proximity of PrP pavement, in an
interdomain region connecting H1, H2 and H3 domains. The
analysis of electrostatic similarity in model I, II and III showed also
that both Ca++-bound w.t. protein and the E200K mutant are
characterized by a significant similarity in the pavement region.
This result indicates that either the mutation or Ca++ binding exert
similar effects in the charge distribution on protein surface.
Importantly, our results indicated that both E200K substitution
and Ca++ binding may reduce the strength of H1–H2 and H1–H3
interactions by a similar mechanism of electrostatic destabilization
affecting the conformational stability of the protein and, thus,
facilitating the PrPC RPrPSc transition.
Consistently with this electrostatic interpretation, it is expected
that the binding of other bivalent metal ions, such as Mg++, Zn++
or Cu++ (whose coordination features can be considered similar to
Ca++) can also induce analogous effects on w.t. protein. This
observation could be particularly relevant for Cu++ considering the
known modulator role of this ion on PrP folding and, possibly,
function [60–63]. The evaluation of Cu++ effects on hPrP90–231
structural, biochemical and biological function is currently in
progress.
Thus, using several different experimental approaches, we
demonstrated that Ca++ binding to hPrP90–231 may favor the
conversion of hPrP90–231 in a neurotoxic conformer. However,
the experimental conditions responsible to convert PrP peptide in
the harmful form are rather extreme (maximum effect at [Ca++]
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10 mM) and it is unlikely to find such a high concentration of the
divalent ions or such a high temperature (53uC in the thermal
denaturation model) in a living organism. However, two consid-
erations should be taken in account. As shown in Figure 5, the
conversion of the peptide in the toxic form can take place even in
‘‘physiological’’ conditions, such as prolonged incubation at
1.8 mM Ca++ and 37uC. The experiments reported in Fig. 5
contain indications that the toxic conformation of hPrP90–231 is
mainly due to small oligomers. Higher toxicity level and
membrane conductance occur early, after 5, 15 and 24 hours
and declines later, presumably due to the formation of bigger
aggregates. Thus, it is realistic to think that high Ca++ level and/or
high temperature work as catalyst to speed up in vitro a
spontaneous reaction. In a healthy system the rate of spontaneous
toxic PrP species formation is compatible with the ability to
efficiently eliminate the misfolded proteins. It is also possible that
the slow production of reactive peptides would favor the direct
aggregation of monomeric PrP in amorphous big aggregates
without the formation of harmful intermediated oligomeric form
[64]. However, it should be also considered a different scenario. If
the rate of PrP misfolded proteins formation drastically increases,
all the system devoted to annihilation of aberrant proteins would
be plugged and this will favored a harmful unbalanced situation.
Misfolded proteins will increase in concentration allowing the
formation of reactive oligomers before the peptides would reach
the amorphous state of big aggregates. Small oligomers in their
short lifespan will be able to react with the biological membrane
causing unregulated ionic flows, most of the time resulting in a
depolarization of the cell membrane potential. Depolarized
neuronal cells could be considered a first stage, even if reversible,
of the disease progression. In addition to that, the formation of
membrane discontinuity could also be the pathway allowing
extracellularly accumulated PrP peptides to leak in the cell to form
aggregates in the cytosol. Cytotoxicity could be the result of both
these factors. Pathogenic PrP, by changing the membrane voltage,
is able to increase intracellular Ca++ concentration through the
activation of both ion channels and ionotropic receptors. Thus, it
is likely that elevation of intracellular Ca++ may interfere with
internalized and neosynthesized PrP molecules causing a structural
alteration within the cell. In this model we have the starting of a
vicious circle in which altered PrP molecules affect intracellular
membrane permeability to Ca++ that reaching high intracellular
levels contribute to the generation of new toxic species that
altogether with the altered Ca++ homeostasis induce synapse
dysfunction and neuronal death.
In conclusion, we suggest that increased membrane permeabil-
ity due to the structural rearrangement of PrP peptide is a
spontaneous long lasting reaction. Increase of membrane conduc-
tance could be linked to pathological conditions once there is an
overproduction of PrP misfolded protein. In this case the system is
not capable to eliminate the dangerous peptide that, both for
environmental conditions and for its concentration, is allowed to
form highly reactive oligomers able to strongly interact with the
cell membrane. The possibility to form high conductance ionic
pathways could be also the vehicle to allow PrP protein inside the
cell. Here the peptide could aggregate and form deposits [18].
Alternatively misfolded PrP could form oligomers and cause
damage to internal membrane such as mitochondria, lysosomes
and nuclear envelope, determine a slowly but inexorable collapse




The protease-resistant core (PrP27–30) of PrPTSE extracted
from brains of TSE-affected hamsters PrP27–30 was kindly
provided by the Pocchiari’s group [31]. Recombinant prion
peptide PrP 90–231 (hPrP90–231) was synthesized in E. coli and
purified as previously reported [15]. The same procedure was used
to purify the E200K and D202N hPrP90–231 mutants [17]. GST
was purified from the empty pGEX-4T-2 vector following the
same procedure used to purify hPrP90–231 [7].
Cell Cultures and Treatments
SH-SY5Y human neuroblastoma cells (ICLC-Biological Bank
and Cell Factory, IRCCS IST Genova, code HTL95013) were
cultured in MEM/F12 (Euroclone, Milano, Italy) supplemented
with 15% fetal bovine serum (Gibco-Invitrogen, Milano, Italy),
2 mM glutamine (Euroclone, Milano, Italy), pen/strep 100 mg/
ml (Euroclone) and grown in 5% CO2 atmosphere at 37uC.
Twenty-four hours after plating, unless otherwise stated, culture
medium was replaced with fresh medium containing a reduced
(2%) FBS content, to induce growth arrest and minimize
spontaneous apoptosis that serum withdrawal causes in this cell
model [32]. Cells were treated for 2 days with a single
administration of hPrP90–231 directly to the culture medium to
mimic the interaction of PrPSc deposits with the neurons as
occurred in vivo [33].
Survival Assay
Mitochondrial function, as index of cell viability, was evaluated
by measuring the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) (Sigma-Aldrich, Milano,
Italy). The cleavage of MTT to a purple formazan byproduct by
mitochondrial dehydrogenases was spectrophotometrically quan-
tified, as reported [34]. Briefly, cells were incubated for 1 h with
0.25 mg/mL MTT in serum-free Dulbecco’s modified Eagle’s
medium at 37uC; medium, was removed and formazan crystals
dissolved in dimethyl-sulfoxide (DMSO). Absorbance values were
measured at wave length of 570 nm. Experiments were performed
in quadruplicate and repeated at least three times. Data are
reported as mean values 6 standard error (S.E.) Statistical analysis
was performed by means of one-way ANOVA followed by
Newman and Keuls test. A p value less than or equal to 0.05 was
considered statistically significant.
Electrophysiological Assay
Single-channel recordings from lipid bilayer were obtained
using the Tip-Dip method. Patch clamp pipettes (Garner Glass
7052) were made using a P97 Sutter Instruments puller (Novato,
CA), coated with Sylgard (Dow Corning, Midland, MI) and fire-
polished to a tip diameter of 1–1.5 mm and 5–7 MOhm resistance.
1,2-diphytanoyl-sn-glycero-3-phosphocholine (Diph-PC, Avanti
Polar Lipids, Inc., Birmingham, AL) was used to arise the lipid
monolayer. An Axopatch 200 B amplifier and pClamp 8
(Molecular Device, Novato, CA) were used to record and analyze,
digitized at 5 kHz and filtered at 1000 Hz the detected current.
Membrane voltages (Vm) and ion currents were expressed
considering relative to the pipette solution. An inward current is
defined as a cation moving from the electrode to the bath
chamber. Data are presented as mean 6 SEM. Values obtained
from different experiments were tested for statistical differences
using independent two population t test or ANOVA routine
(Origin software; Origin Lab, Northampton, MA). Different
buffers were employed in the two compartments. The ion
compositions of the trans solutions were defined in order to
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resemble the physiological composition (144 mM NaCl, 1.8 mM
CaCl2, 1.2 mM MgCl2, 10 mM Hepes, pH 7.0), and the cis
solution to mimic the cytoplasmic ion milieu (144 mM KCl,
0.1 mM CaCl2, 1.2 mM MgCl2, 1.1 EGTA, 10 mM Hepes,
pH 6.2). Samples of hPrP90–231, wt and its E200K and D202N
mutated forms employed in all Tip-Dip assays were made up to a
final concentration of approximately 80 mM in a solution
containing: 144 mM NaCl, 1.8 mM CaCl2, 1.2 mM MgCl2,
10 mM Hepes, pH 5.0 and DMSO 55%. 20 microliters of the
stock solutions were added to 1 ml of the test solutions to a final
concentration of 160 nM. In ion current measurements achieved
in essaying the effect of Ca++, increasing amounts of CaCl2 (5, 10,
20, 50 mM) were added in the trans solution.
Circular Dichroism (CD)
Spectra were measured on a Jasco J-600 spectropolarimeter,
calibrated with camphorsulphonic acid [35]. Samples were diluted
in 10 mM phosphate buffer, pH 7.2. Spectra were recorded
between 200 and 250 nm with a 1 nm spectral step size, 0.5 nm
bandwidth and 100 nm/min scan rate, using 1 mm quartz cell.
Spectra represent the average of 10 scans subtracted of blank
values (10 scans of buffer alone). The experiments were
independently repeated three times.
Thioflavin T (Th T) Binding Assay
Peptides was incubated with 10 mM Th T (Sigma-Aldrich) (in
20 mM NaOPO4, 0.15 M NaCl, pH 7.0) and fluorescence was
monitored using Lambda Bio 10 spectrofluorometer (Perkin
Elmer). Th T fluorescence was measured with excitation at
450 nm and emission from 460 to 560 nm with excitation and
emission slits of 10 nm, as reported [36]. Spectra are reported
subtracted of respective blank values.
2-(p-Toluidinyl)naphthalene-6-sulfonate (TNS) Binding
Assay
This assay was performed with a Spex spectrofluorimeter
(model Floromax) equipped with a temperature-controlled cell
compartment maintained at 18uC using the hydrophobicity
fluorescent probe TNS, as reported [37]. In particular, the
fluorescence emission of the complex hPrP90–231-TNS (1 mM of
peptide plus 100 mM of TNS, dissolved in 2 mM phosphate buffer
pH 6.0) was recorded between 400 and 510 nm, with an
excitation wavelength at 365 nm. The spectra were reported
subtracted of the respective blank solution containing 100 mM
TNS plus 1.8, 5, or 10 mM Ca++.
Intrinsic Fluorescence Measurements
Fluorescence spectra were measured with a Lambda Bio 10
spectrofluorimeter (Perkin-Elmer). Tryptophan emission from of
hPrP90–231 was recorded between 295 and 420 nm, with
excitation at 295 nm. The spectra were reported subtracted of
the respective blank values [37].
hPrP90–231 Proteinase K (PK) Resistance Assay
hPrP90–231 resistance to proteolysis was revealed by immuno-
blotting [7]. Digestion was performed treating 100 mg proteins
with increasing concentrations of PK (1, 2, 10 mg/ml) for 30
minutes at 37uC. Digestion was stopped by boiling samples in
Laemmli buffer. Digestion profile was detected subjecting samples
to 15% SDS-PAGE followed by immunoblotting using the anti
PrP mouse monoclonal antibody 3F4 (epitope corresponding to
amino acids 109–112 in the human PrP: Signet Lab, London,
UK).
Computational Details: Structural Analyses of PrPC Wild
Type and E200K Mutant
The experimental NMR structures of the recombinant wild type
hPrP90–230 and the hPrP90–231 E200K mutant were taken from
the PDB archives, entry code 1QM0 [38] and 1FKC [39],
respectively. The selected entries were graphically inspected and
analyzed to find possible structural mismatches by using the
molecular modelling software Maestro [40].
A geometry minimization has been preliminarily performed for
both proteins, starting from the experimental structures, by using
MacroModel [41] with the OPLS-AA force field [42,43] and a
gradient threshold of 0.05 kJ mol21 A˚21. The water environment
was simulated with the GB/SA implicit solvation model imple-
mented in the program [44].
The structures so obtained correspond to local minima of the
potential energy surfaces (PES) for the two proteins and were then
employed as input for large-scale low mode (LLMOD) searches
[45,46] allowing the characterization of further local minima in a
wider section of their PES. The LLMOD calculations were carried
out by imposing the default set-up to the search variables, carrying
out 1000 Monte Carlo steps before stopping, setting 3.0 and 6.0 A˚
as minimum and maximum distance step, respectively, and
imposing a convergence limit to the local minimization steps of
1.0 kJ mol21 A˚21, to increase the time performances of the
search.
The exploration of the first 30 pure normal modes correspond-
ing to the eigenvectors of the input structure Hessian with the
lowest frequencies was carried out by the global search option,
allowing each Monte Carlo step to begin with the preceding
structure, provided its energy is within 100 kJ mol–1 of the global
minimum.
The LLMOD outputs were subsequently minimized and
characterized as unique structures within a gradient threshold of
0.050 kJ mol21 A˚21, using the multiple minimization module
implemented in MacroModel. The multiple minimization outputs
were further filtered to eliminate high energy conformation and,
eventually, the structure corresponding to the global minimum
was taken as representative of the water solution structure for each
PrPC form, and hereafter referred to as models I and II.
These two models were then superimposed by the minimization
of root mean square deviations (RMSD) of Ca backbone positions.
The resulting structures were centered and aligned with respect to
center of mass and moment of inertia, using the dedicated tool of
Maestro. The direction of the smallest principal moment of inertia,
used as x-axis in the workspace coordinates of Maestro, is almost
aligned with H3, the longest among the three helices character-
izing the three-dimensional structure of PrPC.
Preliminarily, the calculated structures of models I and II were
graphically inspected with Maestro to retrieve qualitative infor-
mation on the main differences and similarities between the two
PrPC forms. In particular, we focused on the distribution of
charged residues on the whole protein surface because of their
major contribution to the molecular electrostatic potential (MEP).
We also characterized salt bridges and most stable hydrogen bonds
(involving charged residues) in terms of intra or interdomain
interactions which are expected to play a major role in the
stabilization of the tertiary structure. A more detailed analysis was
then performed by comparing the MEPs of models I and II in the
space surrounding the superimposed protein models (I U II) by
means of a in-home Perl script (Fig. S1). Both MEPs were probed
on the same three-dimensional grid around the (I U II)
superimposed structure and characterized by a grain of 0.35 A˚
and dimensions of 66647640 A˚, large enough to ensure an
adequate mapping of MEP in the space surrounding the entire
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protein surface. The electrostatic potential on a grid point r was
calculated by using the classical expression:










where N is the number of protein atoms, and R
!
j and qj the vector
associated to position of jth protein atom, and its OPLS-AA
charge, respectively [44].
The MEP similarity between model I and II was then evaluated
at different portion of the grid by the calculation of Carbo´











where VI(i) and VII(i) are the corresponding MEPs calculated at i
th
point, and Npoints is the number of grid points considered for the
calculation of similarity.
Moreover, because the important role played by the H3 helix,
characterizing the whole protein frame, we performed our
similarity analysis with respect to its axis (approximately taken as
the x-axis in the workspace coordinates of Maestro). Accordingly,
the grid space was partitioned into slices in the yz plane, i.e.
perpendicular to the x axis, and sC was calculated on each slice
(defined as a set of 6 layers of points sharing the same x coordinate)
by including only the points external to the protein surface. The
whole grid space was partitioned into 34 slices and the whole
procedure was parallelized thus providing higher computational
performance. An estimate of sC as a function of the position of the
slice along the x axis was thus obtained including in the previous
formula only the points of single yz-slices.
Ca2+ Binding to Wild Type PrPC
The building of a molecular model for the binding of the Ca++
to the PrPC wild type protein (model III) was carried out on the
basis of an inspection of the MEP and of the distribution of
potentially coordinating side chains around the w.t. protein
surface, suggesting a plausible metal binding site in the close
proximity of Arg 156, His187, Thr191 and Glu196 (see Results
and Discussion).
Model I (see above) was used as a template to generate an initial
guess of model III, by using the Maestro graphical interface. Ca++
binding site was generated by moving the side chain of Arg 156
toward the external bulk, using the ‘‘quick torsion’’ tool of
Maestro. The Ca++ ion was then inserted in the site left by the
Arg156 side chain and suitably placed to bind the imidazolic
nitrogen of His 187, the phenolic oxygen of Thr 191, and the
backbone carbonyl oxygen of Arg 156 itself. This structure
underwent the same computational treatment of models I and II
(see above) consisting of local minimization, LLMOD search, and
multiple minimization, which eventually led to model III.
Model III was then compared with models I and II with the
same procedure employed for the comparison between models I
and II. After superposition to model I or II, model III underwent
graphical inspection and the mapping of MEP by using the same
approach employed in the I/II comparison. Carbo´ similarity index
was calculated for both I/III and II/III comparisons as a function
of the position along the x axis and the results were compared to
the corresponding I/II analyses.
Supporting Information
Figure S1 Scheme of the Perl script algorithm for the
mapping of MEP at the protein surface according to the
partitioning scheme into slices along the x axis.
(PDF)
Figure S2 Ribbon view of protein model I (dark green),
II (light cyan) and III (orange) after superposition
through minimization of Ca RMSD. The grid points (red
spheres) corresponding to the two minima of I/II similarity, the
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